Track topics on Twitter Track topics that are important to you
Fontem US Inc. (Fontem), leader in next generation nicotine products and marketer of blu® electronic cigarettes, issued the following statement regarding the ruling by the U.S. District Court for the District of Maryland adjusting the timeline establishing the Food and Drug Administration’s premarket tobacco product application (PMTA) pathway for electronic nicotine delivery systems.
“We are disappointed with the court’s decision imposing an accelerated timeline on the premarket review process. This will undoubtedly hamper the ability of manufacturers to conduct the scientific research needed to ensure that potentially less harmful products are available to adult smokers seeking to make the switch from combustible tobacco products. Fontem has worked in good faith with the FDA as it seeks to establish an appropriate and effective regulatory framework. We share the priority of keeping tobacco products out of the hands of minors and have taken several proactive steps aimed specifically at youth access prevention. The FDA’s initial decision to delay the PMTA process was intended, in its own words, to allow for ‘a multi-year roadmap to better protect kids and significantly reduce tobacco-related disease.’ As recently as June 11, the FDA acknowledged the importance of retaining an achievable timetable even as the court’s initial ruling required the agency to move the goalposts for manufacturers. While we continue to believe that the originally outlined process was the most reasonable approach, Fontem is committed to complying with all applicable laws and regulations wherever our products are sold and will continue to work cooperatively with the FDA.”
About Fontem US, Inc.
Designed for smokers, by smokers, blu has been a trusted leader of adult consumer satisfaction since launching in 2009. blu's top priority and mission continues to be exceeding the needs of adult smokers with high quality vapor products and e-liquid flavors. blu is available online and in stores across the four largest vapor markets worldwide, including the USA, UK, France and Italy. The brand is owned by Fontem Ventures, a subsidiary of the Imperial Brands Group, with international headquarters in Amsterdam, the Netherlands and Charlotte, North Carolina.
blu adheres and is committed to marketing and advertising standards that ensure all communications are intended for and presented to adult audiences only. To discover blu and experience blu satisfaction, visit http://www.blu.com/en/US.
Senior Vice President of External Affairs
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...